Performance of COVID-19 case-based surveillance system in FCT, Nigeria, March 2020-January 2021

被引:4
|
作者
Umeozuru, Chikodi Modesta [1 ,2 ]
Usman, Aishat Bukola [2 ]
Olorukooba, Abdulhakeem Abayomi [3 ]
Abdullahi, Idris Nasir [4 ]
John, Doris Japhet [5 ]
Lawal, Lukman Ademola [5 ]
Uwazie, Charles Chukwudi [1 ,2 ]
Balogun, Muhammad Shakir [2 ]
机构
[1] Nigeria Field Epidemiol & Lab Training Program, Abuja, Nigeria
[2] African Field Epidemiol Network AFENET, Abuja, Nigeria
[3] Ahmadu Bello Univ, Dept Community Med, Zaria, Kaduna, Nigeria
[4] Ahmadu Bello Univ, Dept Med Lab Sci, Zaria, Kaduna State, Nigeria
[5] Fed Capital Terr Adm, Dept Publ Hlth, Abuja, Nigeria
来源
PLOS ONE | 2022年 / 17卷 / 04期
关键词
D O I
10.1371/journal.pone.0264839
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Introduction The emergence of novel SARS-CoV-2 has caused a pandemic of Coronavirus Disease 19 (COVID-19) which has spread exponentially worldwide. A robust surveillance system is essential for correct estimation of the disease burden and containment of the pandemic. We evaluated the performance of COVID-19 case-based surveillance system in FCT, Nigeria and assessed its key attributes. Methods We used a cross-sectional study design, comprising a survey, key informant interview, record review and secondary data analysis. A self-administered, semi-structured questionnaire was administered to key stakeholders to assess the attributes and process of operation of the surveillance system using CDC's Updated Guidelines for Evaluation of Public Health Surveillance System 2001. Data collected alongside surveillance data from March 2020 to January 2021 were analyzed and summarized using descriptive statistics. Results Out of 69,338 suspected cases, 12,595 tested positive with RT-PCR with a positive predictive value (PPV) of 18%. Healthcare workers were identified as high-risk group with a prevalence of 23.5%. About 82% respondents perceived the system to be simple, 85.5% posited that the system was flexible and easily accommodates changes, 71.4% reported that the system was acceptable and expressed willingness to continue participation. Representativeness of the system was 93%, stability 40%, data quality 56.2% and timeliness 45.5%, estimated result turnaround time (TAT) was suboptimal. Conclusion The system was found to be useful, simple, flexible, sensitive, acceptable, with good representativeness but the stability, data quality and timeliness was poor. The system meets initial surveillance objectives but rapid expansion of sample collection and testing sites, improvement of TAT, sustainable funding, improvement of electronic database, continuous provision of logistics, supplies and additional trainings are needed to address identified weaknesses, optimize the system performance and meet increasing need of case detection in the wake of rapidly spreading pandemic. More risk-group persons should be tested to improve surveillance effectiveness.
引用
收藏
页数:20
相关论文
共 50 条
  • [1] Association Between COVID-19 and Myocarditis Using Hospital-Based Administrative Data - United States, March 2020-January 2021
    Boehmer, Tegan K.
    Kompaniyets, Lyudmyla
    Lavery, Amy M.
    Hsu, Joy
    Ko, Jean Y.
    Yusuf, Hussain
    Romano, Sebastian D.
    Gundlapalli, Adi, V
    Oster, Matthew E.
    Harris, Aaron M.
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2021, 70 (35): : 1228 - 1232
  • [2] Risk of hospitalization and death for healthcare workers with COVID-19 in nine European countries, January 2020-January 2021
    Ferland, L.
    Carvalho, C.
    Dias, J. Gomes
    Lamb, F.
    Adlhoch, C.
    Suetens, C.
    Beaute, J.
    Kinross, P.
    Plachouras, D.
    Hannila-Handelberg, T.
    Fabiani, M.
    Riccardo, F.
    Van Gageldonk-Lafeber, A. B.
    Teirlinck, A. C.
    Mossong, J.
    Vergison, A.
    Melillo, J.
    Melillo, T.
    Mook, P.
    Pebody, R.
    Rehse, A. P. Coutinho
    Monnet, D. L.
    JOURNAL OF HOSPITAL INFECTION, 2022, 119 : 170 - 174
  • [3] Epidemiological Comparison of Four COVID-19 Waves in the Democratic Republic of the Congo, March 2020-January 2022
    Otshudiema, John Otokoye
    Folefack, Gervais Leon T.
    Nsio, Justus M.
    Mbala-Kingebeni, Placide
    Kakema, Cathy H.
    Kosianza, Joel B.
    Mfumu, Antoine K.
    Saidi, Guy N.
    Kabongo, Patrice M.
    Okum, Raphael
    Tshimbombu, Tshibambe N.
    Ahuka-Mundeke, Steve
    Karamagi, Humphrey Cyprian
    Muyembe, Jean-Jacques T.
    Djiguimde, Amedee Prosper
    JOURNAL OF EPIDEMIOLOGY AND GLOBAL HEALTH, 2022, 12 (03) : 316 - 327
  • [4] Community-Associated Outbreak of COVID-19 in a Correctional Facility - Utah, September 2020-January 2021
    Lewis, Nathaniel M.
    Salmanson, Amelia Prebish
    Price, Andrea
    Risk, Ilene
    Guymon, Colleen
    Wisner, Marcus
    Gardner, Kyle
    Fukunaga, Rena
    Schwitters, Amee
    Lambert, Lauren
    Baggett, Henry C.
    Ewetola, Raimi
    Dunn, Angela C.
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2021, 70 (13): : 467 - 472
  • [5] Association Between Prison Crowding and COVID-19 Incidence Rates in Massachusetts Prisons, April 2020-January 2021
    Leibowitz, Abigail, I
    Siedner, Mark J.
    Tsai, Alexander C.
    Mohareb, Amir M.
    JAMA INTERNAL MEDICINE, 2021, 181 (10) : 1315 - 1321
  • [6] COVID-19 Scientific Publications From the Centers for Disease Control and Prevention, January 2020-January 2022
    Meites, Elissa
    Knuth, Martha
    Hall, Kaely
    Dawson, Patrick
    Wang, Teresa W.
    Wright, Marcienne
    Yu, Wei
    Senesie, Schabbethai
    Stephenson, Elizabeth
    Imachukwu, Chukwuebuka
    Sayi, Takudzwa
    Gurbaxani, Brian
    Svendsen, Erik R.
    Khoury, Muin J.
    Ellis, Barbara
    King, Brian A.
    PUBLIC HEALTH REPORTS, 2023, 138 (02) : 241 - 247
  • [7] First Month of COVID-19 Vaccine Safety Monitoring - United States, December 14, 2020-January 13, 2021
    Gee, Julianne
    Marques, Paige
    Su, John
    Calvert, Geoffrey M.
    Liu, Ruiling
    Myers, Tanya
    Nair, Narayan
    Martin, Stacey
    Clark, Thomas
    Markowitz, Lauri
    Lindsey, Nicole
    Zhang, Bicheng
    Licata, Charles
    Jazwa, Amelia
    Sotir, Mark
    Shimabukuro, Tom
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2021, 70 (08): : 283 - 288
  • [8] Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US-December 14, 2020-January 18, 2021
    Shimabukuro, Tom T.
    Cole, Matthew
    Su, John R.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (11): : 1101 - 1102
  • [9] Adverse events of the COVID-19 vaccines reported to the vaccine adverse event reporting system (VAERS), December 14, 2020-January 22, 2021
    Xue, Xiangzhong
    Zou, Chenyu
    Qian, Jingjing
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 137 - 137
  • [10] Epidemiological Surveillance of COVID-19, in the Province of Callao in Peru, from March 2020 to June 2021
    Gomez Zeballos, C.
    Gonzalez Collantes, S. D. C.
    Perez Davila, J.
    Robles Camarena, R.
    Minaya Sanchez, S. A.
    Quinonez Rodriguez, J. P.
    Ochoa Palomino, J.
    Ramon Ricaldi, K.
    Penadillo Cueva, L.
    Rengifo Calderon, G.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 116 : S28 - S28